Schedule 13D ownership disclosure

Artiva Biotherapeutics, Inc.

Security class unavailable · CUSIP: 04317A107

Event date: 2024-08-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,853,302
Percent of class
40.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-096378
Form type
SC 13D/A
Filer
Artiva Biotherapeutics, Inc.
CIK
CIK 1817241
Filed
Sep 03, 2024
Reporting period
Aug 29, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub